A Tylenol plant in suburban Philadelphia was shut down after Food and Drug Administration inspectors reported serious quality and safety violations. The report could lead to tough action by regulators on Johnson & Johnson. "It's absolutely shocking," said David Lebo, assistant professor of pharmaceutics at Temple's School of Pharmacy, referring to the FDA's report on the facility in Fort Washington. "This inspection report is pretty close to being the worst I've seen." The report also said the company failed to follow up on consumer complaints. "When you get consumer complaints you want to make sure you at least investigate them," said Albert Wertheimer, a professor of pharmaco-economics at the School of Pharmacy.